Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Journal Title
- Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
ISSN
- E 2352-8729
Publisher
- Elsevier BV
Listed on(Coverage)
| SJR | 2016-2019 |
|---|---|
| CiteScore | 2016-2019 |
| SCOPUS | 2017-2020 |
| DOAJ | 2020-2021 |
| EMBASE | 2016-2020 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | geriatrics, dementia risk factors, dementia detection, biomarkers, memory disorders |
| Review Process | Blind peer review |
| Journal info. pages | |
| Licences | CC BY-NC-ND |
| Copyrights | No |
| DOAJ Coverage |
|
| Subject(s) | Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system | Medicine: Internal medicine: Special situations and conditions: Geriatrics |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- NETHERLANDS
Aime & Scopes
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access, peer-reviewed, journal from the Alzheimer's Association® that will publish new research that reports the discovery, development and validation of instruments, technologies, algorithms, and innovative processes. Papers will cover a range of topics interested in the early and accurate detection of individuals with memory complaints and/or among asymptomatic individuals at elevated risk for various forms of memory disorders. The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies. Given the growing number of specialized manuscripts in the field of Alzheimer's and dementia research, DADM will provide an expanded platform to provide a) rapid communication and publication that facilitate cross-fertilization of ideas, b) integrating and translating knowledge across disciplines; disseminating basic and clinical information necessary for optimal translation of research into practical applications and interventions, c) increase knowledge in diverse areas of studies with potentials/implications for practical application related to early detection and/or interventions, d) formulating crucial experiments necessary for the rigorous testing of theories or their predictions, and e) identifying promising new directions of research and providing the impetus or the scientific foundation for new initiatives on interventions.